News | July 22, 2024
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Subscribe To Our Newsletter & Stay Updated
